The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients

BACKGROUND: Besides the conventional therapy for heart failure, the diuretics, cardiac glycosides and ACE-inhibitors, current pharmacotherapy includes beta-blockers, mainly because of their pathophysiological mechanisms upon heart remodeling. AIM: The study objective was to assess the cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Taneva, Borjanka, Caparoska, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884262/
https://www.ncbi.nlm.nih.gov/pubmed/27275338
http://dx.doi.org/10.3889/oamjms.2016.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884262/
https://www.ncbi.nlm.nih.gov/pubmed/27275338
http://dx.doi.org/10.3889/oamjms.2016.022

Ejemplares similares